FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Case insensitive SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Interferon beta-1b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b 200 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine 100 mg lyophilised powder for solution for injection vial Plays role False Antineoplastic therapeutic role Inferred relationship Some
Azacitidine 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine 300 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 1 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 2 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab 5 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idelalisib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idelalisib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idelalisib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin 50 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ceritinib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bortezomib 3.5 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate only product in cutaneous dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate-containing product in cutaneous dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cobimetinib (as cobimetinib fumarate) 20 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Everolimus 2.5 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Anthracycline antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinca alkaloid antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nitrogen mustard derivative antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nitrosurea antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Purine analogue antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pyrimidine analogue antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Podophyllotoxin and/or podophyllotoxin derivative antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Monoclonal antibody antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab 2 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Epidermal growth factor receptor antagonist antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Duvelisib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Duvelisib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix 120 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 300 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine (as vinorelbine tartrate) 10 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin 50 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 2 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 1 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 160 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 100 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rituximab 10 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Irinotecan hydrochloride trihydrate 20 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cladribine 1 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab 5 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 500 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 400 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 2 g powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 200 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 500 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilotinib (as nilotinib hydrochloride) 200 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 1 g powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib (as tepotinib hydrochloride) 225 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib (as umbralisib tosylate) 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 14 of 16 Next End

Reference Sets

Qualifier value foundation reference set

Back to Start